Search

Search Constraints

You searched for: Author/Creator Mak, Elijah

Search Results

2. [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. (29th May 2018)

3. [18F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases. Issue 3 (28th August 2021)

4. [IC‐03–02]: [11C]PK11195 PET IN ALZHEIMER's DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY: THE NIMROD STUDY. (1st July 2017)

5. [IC‐P‐074]: LONGITUDINAL DIFFUSION TENSOR IMAGING AS A PREDICTOR OF COGNITIVE DOMAINS DECLINE IN EARLY STAGE PARKINSON's DISEASE: ICICLE‐PD STUDY. (1st July 2017)

6. [IC‐P‐078]: [11C]PK11195 PET IMAGING REVEALS NEUROINFLAMMATION IN DEMENTIA WITH LEWY BODIES IS NEGATIVELY ASSOCIATED WITH DISEASE SEVERITY: NIMROD STUDY. (1st July 2017)

7. [IC‐P‐191]: IN VIVO MAPPING OF TAU DEPOSITION, PERFUSION, AND CORTICAL THINNING IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE. (1st July 2017)

8. [IC‐P‐200]: INVESTIGATE THE RELATIONSHIP BETWEEN TAU AND NEUROINFLAMMATION IN ALZHEIMER's DISEASE USING PET AND REACTION RATE MODELLING. (1st July 2017)

9. [O3–09–04]: INVESTIGATION OF THE RELATIONSHIP BETWEEN TAU AND NEUROINFLAMMATION IN ALZHEIMER's DISEASE USING PET AND REACTION MODELLING. (1st July 2017)

10. [O4–04–04]: [18F]AV‐1451 PET IMAGING OF TAU PATHOLOGY PREDICTS WHITE MATTER HYPERINTENSITIES IN HEALTHY AGING, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: THE NIMROD STUDY. (1st July 2017)